0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 39,554 1,500 41,054 41,054 39,554 xbrli:pure xbrli:shares iso4217:GBP 11737143 2024-01-01 2024-12-31 11737143 2024-12-31 11737143 2023-12-31 11737143 2023-01-01 2023-12-31 11737143 2023-12-31 11737143 2022-12-31 11737143 bus:Director2 2024-01-01 2024-12-31 11737143 core:WithinOneYear 2024-12-31 11737143 core:WithinOneYear 2023-12-31 11737143 core:ShareCapital 2024-12-31 11737143 core:ShareCapital 2023-12-31 11737143 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 11737143 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 11737143 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 11737143 core:Non-currentFinancialInstruments 2024-12-31 11737143 core:Non-currentFinancialInstruments 2023-12-31 11737143 bus:SmallEntities 2024-01-01 2024-12-31 11737143 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 11737143 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11737143 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11737143 bus:FullAccounts 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 11737143

Intergen Homes Limited

Filleted Unaudited Financial Statements

31 December 2024

Intergen Homes Limited

Financial Statements

Year ended 31 December 2024

Contents | Page

Statement of financial position | 1

Notes to the financial statements | 3

Intergen Homes Limited

Statement of Financial Position

31 December 2024

| 2024 | 2023
Note | £ | £

Fixed assets

Investments | 4 | 41,054 | 39,554

Current assets

Stocks | 149,900 | 42,215
Debtors | 5 | 8,958 | 4,108
| --------- | --------
| 158,858 | 46,323

Creditors: amounts falling due within one year | 6 | 199,812 | 85,777
| --------- | --------
Net current liabilities | 40,954 | 39,454
| -------- | --------
Total assets less current liabilities | 100 | 100
| ---- | ----
Net assets | 100 | 100
| ---- | ----

Capital and reserves

Called up share capital | 100 | 100
| ---- | ----
Shareholders funds | 100 | 100
| ---- | ----

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Intergen Homes Limited

Statement of Financial Position (continued)

31 December 2024
These financial statements were approved by the board of directors and authorised for issue on 18 March 2026 , and are signed on behalf of the board by:

Mr S K Sheldon
Director

Company registration number: 11737143

Intergen Homes Limited

Notes to the Financial Statements

Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Midway House, Staverton Technology Park , Herrick Way, Staverton, Cheltenham, Gloucestershire, GL51 6TQ, UK.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
4. Investments

| Other investments other than loans
| £
Cost |
At 1 January 2024 | 39,554
Additions | 1,500
| --------
At 31 December 2024 | 41,054
| --------
Impairment |
At 1 January 2024 and 31 December 2024 | –
| --------

Carrying amount |
At 31 December 2024 | 41,054
| --------
At 31 December 2023 | 39,554
| --------

5. Debtors

| 2024 | 2023
| £ | £
Other debtors | 8,958 | 4,108
| ------- | -------

6. Creditors: amounts falling due within one year

| 2024 | 2023
| £ | £
Trade creditors | 1,923 | –
Amounts owed to group undertakings and undertakings in which the company has a participating interest | 195,401 | 85,289
Other creditors | 2,488 | 488
| --------- | --------
| 199,812 | 85,777
| --------- | --------

7. Related party transactions
During the year the company received a further loan of £110,112 from Harper Sheldon Limited, a company registered in England and Wales and a related party by virtue of Mr S K Sheldon 's common directorship. At the year end an amount of £195,401 (2023 £85,288) was outstanding. This loan has no interest or repayment terms.